Issue Date: September 4, 2017
Evolva restructures as part of sales drive
The Swiss industrial biotech firm Evolva will reduce its workforce to 100 employees, from 178, to focus on commercializing its fermentation-derived food ingredients and increasing sales. The company makes food and nutraceutical ingredients including resveratrol, stevia, and vanillin via fermentation with modified microbes. Evolva named a new CEO in July; three other executives will step down by the end of the year. Evolva will also consolidate research activities at its headquarters in Reinach.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society